Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Pulmonary Hypertension

Free Subscription 15.06.2026 1 Ann Thorac Surg Short Rep 1 Arch Bronconeumol 1 Arch Cardiovasc Dis 1 Can J Infect Dis Med Microbiol 2 Chest 1 Chron Respir Dis 1 Circ Rep 1 Circulation 2 Clin Case Rep 1 Clin Perinatol 1 Compr Physiol 1 Cureus 1 Curr Opin Pulm Med 4 Echo Res Pract 2 ERJ Open Res 1 Eur Heart J Case Rep 1 Eur Heart J Open 1 Eur J Hum Genet 1 Front Cardiovasc Med 1 Front Immunol 1 Front Med (Lausanne) 1 Front Pharmacol 1 Heart Lung 1 Int J Mol Sci 1 J Am Heart Assoc 2 J Clin Med 1 J Family Med Prim Care 1 J Heart Lung Transplant 1 J Struct Biol 1 J Vis Exp 1 JACC Cardiovasc Imaging 1 Life Sci 1 Medicine (Baltimore) 1 Mol Immunol 1 Niger J Clin Pract 1 Open Heart 1 Phytomedicine 1 PLoS One 1 Pulm Circ 1 Rev Esp Cardiol (Engl Ed) 1 Rheumatology (Oxford) 1 Vasc Med 1 Vascul Pharmacol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Thorac Surg Short Rep

1. CUSMAI C, Gulati S, Laskey D, Sun T, et al
   Successful Single Lung Transplantation in Severe Group III Pulmonary Hypertension.
   Ann Thorac Surg Short Rep. 2025;4:423-427.
   PubMed         Abstract available
   
   

   
   Arch Bronconeumol

2. KOHLI A, Mokhlesi B
   Positive Airway Pressure Therapy for Pulmonary Hypertension Associated with Sleep-disordered Breathing.
   Arch Bronconeumol. 2026 May 11:S0300-2896(26)00171.
   PubMed        
   
   

   
   Arch Cardiovasc Dis

3. GHENGHEA R, Pyra P, Dulac Y, Guitarte A, et al
   Myocardial work during various right ventricle load conditions in a paediatric population.
   Arch Cardiovasc Dis. 2026;119.
   PubMed         Abstract available
   
   

   
   Can J Infect Dis Med Microbiol

4. ABDUL KHALEK J, Al Hajjar M, Al-Khalil Z, Salem J, et al
   Unveiling the Link Between COVID-19 and Pulmonary Hypertension.
   Can J Infect Dis Med Microbiol. 2026;2026:9352258.
   PubMed         Abstract available
   
   

   
   Chest

5. TOSHNER M, Morris N
   Actigraphy in Pulmonary Hypertension Clinical Trials: Time to Step Up?
   Chest. 2026;169:1444-1446.
   PubMed        
   
   
6. LYON ZM, Kolaitis NA
   Is It Time to Focus Efforts to Better Understand Group 3 Pulmonary Hypertension in Patients With Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis?
   Chest. 2026;169:1432-1433.
   PubMed        
   
   

   
   Chron Respir Dis

7. ROBERTSON L, Bunclark K, Toshner M, Pepke-Zaba J, et al
   Diurnal and seasonal variation in six-minute walk distance in pulmonary hypertension: Implications for clinical monitoring.
   Chron Respir Dis. 2026;23:14799731261460039.
   PubMed         Abstract available
   
   

   
   Circ Rep

8. KISHIGAMI D, Shimokawahara H, Takahashi K, Kobashi S, et al
   Three-Color SUV(LV)-Normalized SPECT/CT to Visualize Dynamic Pulmonary Perfusion in Chronic Thromboembolic Pulmonary Hypertension.
   Circ Rep. 2026;8:1011-1012.
   PubMed         Abstract available
   
   

   
   Circulation

9. WANG Q, Tian J, Liu D, Zheng T, et al
   Endothelial SHMT2 Drives Pulmonary Vascular Remodeling Through Noncanonical Pathway in Pulmonary Hypertension.
   Circulation. 2026 Jun 10. doi: 10.1161/CIRCULATIONAHA.125.066183.
   PubMed         Abstract available
   
   

   
   Clin Case Rep

10. NILSSON CN, Aljohani OA, Smith MA, Durand R, et al
    Trametinib Therapy for Hypertrophic Cardiomyopathy and Pulmonary Hypertension in a Child With RAF1-Related Noonan Syndrome (p.Ser257Leu): A Case Report.
    Clin Case Rep. 2026;14:e72831.
    PubMed         Abstract available
    
    
11. AHANGAR H, Ghasemi Palangi M, Gohari S, Yasami P, et al
    A Case of Chronic Thromboembolic Pulmonary Hypertension and Pregnancy, Managed With Pulmonary Endarterectomy: Clinical Challenges, Case Report, and Literature Review.
    Clin Case Rep. 2026;14:e72864.
    PubMed         Abstract available
    
    

    
    Clin Perinatol

12. MOOERS EA, Lakshminrusimha S, Konduri GG
    Advances in the Management of Persistent Pulmonary Hypertension of the Newborn.
    Clin Perinatol. 2026;53:297-316.
    PubMed         Abstract available
    
    

    
    Compr Physiol

13. KUMAR A, Mahajan A, Krishnamachary B, Chen L, et al
    Exposure Pattern Determines Methamphetamine-Induced Right Ventricular Dysfunction and Vascular Remodeling.
    Compr Physiol. 2026;16:e70191.
    PubMed         Abstract available
    
    

    
    Cureus

14. TAMILSELVAN K, Arumugam A, Vadivelu M, Senthilkumar K, et al
    Prevalence and Associated Echocardiographic Findings of Pulmonary Hypertension in Chronic Kidney Disease: A Cross-Sectional Study.
    Cureus. 2026;18:e108609.
    PubMed         Abstract available
    
    

    
    Curr Opin Pulm Med

15. BIRNHUBER A, Zeder K, Kwapiszewska G
    Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.
    Curr Opin Pulm Med. 2026 Jun 11. doi: 10.1097/MCP.0000000000001284.
    PubMed         Abstract available
    
    

    
    Echo Res Pract

16. HERMANSSON FN, Celestin BE, Bagherzadeh SP, Fahed G, et al
    Impact of guideline definitions on right ventricular diameter in echocardiography: an automated analysis in controls and patients with pulmonary hypertension.
    Echo Res Pract. 2026;13:21.
    PubMed         Abstract available
    
    
17. WILD CJB, Coghlan G, Charalampopoulos A, Hameed A, et al
    The impact of right ventricular free wall strain on current international echocardiography guidelines for the assessment of pulmonary hypertension.
    Echo Res Pract. 2026;13:17.
    PubMed         Abstract available
    
    
18. DAOUD A, Goldin G, Goren L, Bagga A, et al
    Echocardiographic characterization of combined postcapillary and precapillary pulmonary hypertension in systemic sclerosis with preserved ejection fraction.
    Echo Res Pract. 2026;13:18.
    PubMed         Abstract available
    
    
19. KARIA N, Murphy D, Howard L, Johnson M, et al
    Significance of echocardiographic metrics including TRV and TAPSE/SPAP in mild haemodynamic pulmonary hypertension - data from EVIDENCE-PAH UK.
    Echo Res Pract. 2026;13:20.
    PubMed         Abstract available
    
    

    
    ERJ Open Res

20. BROSSAT C, Jambon-Barbara C, Hlavaty A, Chaumais MC, et al
    Fenfluramine-associated pulmonary hypertension: a study of adverse events reporting system FAERS.
    ERJ Open Res. 2026;12:01450-2025.
    PubMed         Abstract available
    
    
21. PLUNKETT MJ, Sayegh ALC, Lewis RA, McWilliams TJ, et al
    Slow deep breathing reduces muscle sympathetic nerve activity and improves breathing efficiency in pulmonary hypertension.
    ERJ Open Res. 2026;12:01329-2025.
    PubMed         Abstract available
    
    

    
    Eur Heart J Case Rep

22. KASAHARA T, Yamashita J, Komatsu I, Shimahara Y, et al
    Combined therapeutic strategy of balloon pulmonary angioplasty before and after pulmonary endarterectomy in a patient with severe chronic thromboembolic pulmonary hypertension with Kartagener's syndrome: a case report.
    Eur Heart J Case Rep. 2025;10:ytaf349.
    PubMed         Abstract available
    
    

    
    Eur Heart J Open

23. FARINA JM, Scalia IG, Pietri MP, Abbas MT, et al
    Evaluation of ePLAR, the echocardiographic pulmonary to left atrial ratio, in a large cohort with pulmonary hypertension.
    Eur Heart J Open. 2025;6:oeaf174.
    PubMed         Abstract available
    
    

    
    Eur J Hum Genet

24. MIRANDA-ALCARAZ L, Mora-Gomez M, Gallego-Zazo N, Cruz-Utrilla A, et al
    Expanding the genetic burden of low-evidence genes in pulmonary arterial hypertension.
    Eur J Hum Genet. 2026;34:831-839.
    PubMed         Abstract available
    
    

    
    Front Cardiovasc Med

25. ZHANG JJ, Huang YQ, Liu XK, Sun XL, et al
    Research advances in chronic thromboembolic pulmonary hypertension: from pathological mechanisms to multidisciplinary management.
    Front Cardiovasc Med. 2026;13:1832792.
    PubMed         Abstract available
    
    

    
    Front Immunol

26. POSEY JN, Jordan M, Olsen-Dufour A, Nguyen TN, et al
    Interferon receptor gene dosage differentially regulates hypoxia-induced platelet activation and pulmonary hypertension in down syndrome.
    Front Immunol. 2026;17:1832057.
    PubMed         Abstract available
    
    

    
    Front Med (Lausanne)

27. LESCANO A, Pulido Zamudio T, Conde Camacho R, Caro FM, et al
    Latin American expert opinion paper on the diagnosis and treatment of pulmonary hypertension associated with interstitial lung disease.
    Front Med (Lausanne). 2026;13:1798347.
    PubMed         Abstract available
    
    

    
    Front Pharmacol

28. RYSZKIEWICZ P, Remiszewski P, Pedzinska-Betiuk A, Minczuk K, et al
    Chronic simultaneous inducible nitric oxide synthase (iNOS) and peripheral cannabinoid CB(1) receptors blockade ameliorates pulmonary hypertension in monocrotaline-induced rat model.
    Front Pharmacol. 2026;17:1831802.
    PubMed         Abstract available
    
    

    
    Heart Lung

29. AWAD A, Hamza M, Rayes A, Al Haly B, et al
    Impact of pulmonary hypertension on long-term clinical outcomes in patients undergoing percutaneous coronary intervention for acute coronary syndrome: Results from a large PCI registry.
    Heart Lung. 2026;79:102841.
    PubMed         Abstract available
    
    

    
    Int J Mol Sci

30. CHEN X, Su J, Liu H, Qin Y, et al
    Endothelial-to-Mesenchymal Transition Mechanisms in Vascular Remodeling of Pulmonary Hypertension.
    Int J Mol Sci. 2026;27:4951.
    PubMed         Abstract available
    
    

    
    J Am Heart Assoc

31. LIU J, Guo Y, Huang J, Gao Z, et al
    Adipokine Nesfatin-1 Mediates Endothelial Dysfunction by Suppressing MEF2B/BMPR1A During Pulmonary Vascular Remodeling.
    J Am Heart Assoc. 2026;15:e047528.
    PubMed         Abstract available
    
    

    
    J Clin Med

32. LARPNARONGCHAI S, Maneenil G, Thatrimontrichai A, Dissaneevate S, et al
    Clinical Factors Associated with Ventilator-Free Days in Newborns with Persistent Pulmonary Hypertension of the Newborn: A Retrospective Cohort Study in Thailand.
    J Clin Med. 2026;15:4377.
    PubMed         Abstract available
    
    
33. ROSTAGNO C, Cartei A, Rubbieri G, Ceccofiglio A, et al
    Echocardiography Does Not Delay Surgery in Elderly Patients with Hip Fractures, and Pulmonary Hypertension and Decreased Left Ventricular Ejection Fraction Are Associated with In-Hospital Mortality.
    J Clin Med. 2026;15:4284.
    PubMed         Abstract available
    
    

    
    J Family Med Prim Care

34. DEVALLA L, Wagh PB, Ghewade B
    A rare etiology of pulmonary hypertension: The scimitar syndrome.
    J Family Med Prim Care. 2026;15:1445-1447.
    PubMed         Abstract available
    
    

    
    J Heart Lung Transplant

35. KIM NH, Perez VJ, Kingrey J, David Hardy W, et al
    Methamphetamine-associated PAH on the rise in the US: geographic trends & disparities in patient demographics and treatment strategies.
    J Heart Lung Transplant. 2026;45:1123-1132.
    PubMed         Abstract available
    
    

    
    J Struct Biol

36. BOROVIKOVA I, Uporov I, Okhrimenko G, Zamyatin V, et al
    Molecular dynamics simulations refine the pathogenicity of ACVRL1 kinase domain variants by quantifying impacts on ATP binding in pulmonary arterial hypertension.
    J Struct Biol. 2026;218:108315.
    PubMed         Abstract available
    
    

    
    J Vis Exp

37. BAUER M, Santhanam L, Steppan J
    Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease.
    J Vis Exp. 2026;.
    PubMed         Abstract available
    
    

    
    JACC Cardiovasc Imaging

38. NASER JA, Ibrahim HH, Rahme S, Andi K, et al
    Prognostic Value of Tricuspid Regurgitation in Pulmonary Hypertension and Among the Different WHO Groups.
    JACC Cardiovasc Imaging. 2026 Jun 10:S1936-878X(26)00260.
    PubMed         Abstract available
    
    

    
    Life Sci

39. CHEN S, Yin J, Kan Z, Li X, et al
    Angiopoietin-2-mediated integrin alpha5beta1 and FAK signaling contributes to pulmonary arterial hypertension pathogenesis.
    Life Sci. 2026;399:124441.
    PubMed         Abstract available
    
    

    
    Medicine (Baltimore)

40. DING QS, Li M, Wang YH, Li L, et al
    Echocardiographic evaluation of right ventricular function before and after percutaneous coronary intervention in patients with coronary artery disease and pulmonary hypertension: A single-center retrospective cohort study.
    Medicine (Baltimore). 2026;105:e49028.
    PubMed         Abstract available
    
    

    
    Mol Immunol

41. MA Q, You S
    Neutrophil extracellular traps-related biomarkers in idiopathic pulmonary arterial hypertension: A machine learning-based identification and experimental validation study.
    Mol Immunol. 2026;195:25-39.
    PubMed         Abstract available
    
    

    
    Niger J Clin Pract

42. AKTAS I, Yasar E
    Neutrophil Percentage-to-Albumin Ratio as a Novel Biomarker in Patients with Group 1 Pulmonary Arterial Hypertension.
    Niger J Clin Pract. 2026;29:559-566.
    PubMed         Abstract available
    
    

    
    Open Heart

43. LI OM, Ghani H, Appenzeller P, Amaral-Almeida L, et al
    Comparing bridging drug therapy approaches prior to balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: a prospective analysis from the national UK CURATE registry.
    Open Heart. 2026;13:e004169.
    PubMed         Abstract available
    
    

    
    Phytomedicine

44. GONG D, Liu R, Deng X, Xing J, et al
    Licochalcone B alleviates pulmonary vascular remodeling via inhibiting Furin/TGF-beta1 in pulmonary hypertension.
    Phytomedicine. 2026;158:158373.
    PubMed         Abstract available
    
    

    
    PLoS One

45. HOSOKAWA K, Yamasaki Y, Kishimoto J, Nagayama T, et al
    Facilitating early diagnosis of chronic thromboembolic pulmonary hypertension with dynamic chest radiography: Protocol for a multicenter, assessor-blinded, case-wise randomized superiority reader study (FIND-DCR).
    PLoS One. 2026;21:e0350858.
    PubMed         Abstract available
    
    

    
    Pulm Circ

46. FUJII H, Isobe S, Taniguchi Y, Tamura Y, et al
    Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension in an Adolescent With a Novel Frameshift Variant in PROS1.
    Pulm Circ. 2026;16:e70335.
    PubMed         Abstract available
    
    

    
    Rev Esp Cardiol (Engl Ed)

47. HINOJOSA W, Rodriguez-Munoz D, Lopez-Alacid I, Ynsaurriaga FA, et al
    Atrial flutter ablation in pulmonary hypertension: a national referral center experience.
    Rev Esp Cardiol (Engl Ed). 2026 Jun 11:S1885-5857(26)00127.
    PubMed        
    
    

    
    Rheumatology (Oxford)

48. WELLS M, Smith T, Domsic RT, Anilkumar A, et al
    The clinical utility of telangiectasia quantification as markers of vascular disease progression in systemic sclerosis.
    Rheumatology (Oxford). 2026;65:keag267.
    PubMed         Abstract available
    
    

    
    Vasc Med

49. PORRES-AGUILAR M, Johns E, Piazza G, McBane R, et al
    Exercise for treatment and prevention of post-pulmonary embolism syndrome: A review.
    Vasc Med. 2026;31:409-420.
    PubMed         Abstract available
    
    

    
    Vascul Pharmacol

50. MANZI G, Badagliacca R, D'Alto M, Ghio S, et al
    2025 expert consensus on the use of parenteral prostanoids in incident and prevalent PAH patients: The Italian perspective.
    Vascul Pharmacol. 2026;163:107590.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum